Since first described in the early 1900s, Alzheimer's disease (AD) has risen exponentially in
prevalence and concern. Research still drives to understand the etiology and pathogenesis …

Here we review the impact of obstructive sleep apnea (OSA) on biomarkers of Alzheimer's
disease (AD) pathogenesis, neuroanatomy, cognition and neurophysiology, and present the …

Sleep monitoring may provide markers for future Alzheimer's disease; however, the
relationship between sleep and cognitive function in preclinical and early symptomatic …

Introduction Cognitive impairment is the hallmark of Alzheimer's disease (AD) and related
dementias. However, motor decline has been recently described as a prodromal state that …

Sleep abnormalities may represent an independent risk factor for neurodegeneration. An
international expert group convened in 2021 to discuss the state-of-the-science in this …

In the context of geriatric research, a growing body of evidence links normal age-related
changes in sleep with many adverse health outcomes, especially a decline in cognition in …

Introduction Parkinson's disease (PD) is a chronic neurodegenerative disorder that presents
with motor and non‐motor manifestations. Amongst the non‐motor features, various forms of …

Sleep abnormalities are widely reported in patients with Alzheimer's disease (AD) and are
linked to cognitive impairments. Sleep abnormalities could be potential biomarkers to detect …

Accumulating evidence supports a bidirectional relationship between sleep disruption and
Alzheimer's disease (AD) pathology. Among various sleep electroencephalography …

Sleep fragmentation (SF) is a common sleep problem experienced during the perioperative
period by older adults, and is associated with postoperative cognitive dysfunction (POCD) …